Edit Content
Bizwit-Logo-Final

Bizwit Research & Consulting LLP is a global provider of business intelligence & consulting services. We have a strong primary base of key industry leaders along with the chain of industry analysts to analyze the market trends and its future impact in order to estimates and forecast different business segments and markets. 

Global Neurological Biomarkers Market to reach USD 14.3 billion by 2027.

Global Neurological Biomarkers Market Size study, by Application (Alzheimer’s, Parkinson’s, Multiple Sclerosis, Autism Spectrum Disorder, Others), By Type (Genomic, Proteomic, Metabolomic, Imaging, Others), By End-use (Hospital & Hospital Laboratories, Independent Clinical Diagnostic Centers, Research Organizations and Others) and Regional Forecasts 2021-2027

Product Code: HLSB-96850272
Publish Date: 25-09-2021
Page: 200

Global Neurological Biomarkers Market is valued approximately USD 6.1 billion in 2020 and is anticipated to grow with a healthy growth rate of more than 12.9% over the forecast period 2021-2027. Alzheimer’s disease and Parkinson’s disease are neurodegenerative illnesses that cause progressive loss of cognitive function, dementia, and movement difficulties. The rise in the incidence of neurological diseases such as migraines, dementia, Alzheimer’s disease, brain tumours, and epilepsy can be contributed to the market’s expansion. Furthermore, technological advances and the growing demand for early detection of neurological diseases are driving the market growth. In 2019, according to the WHO (World Health Organization), epilepsy accounted for about 13 million disability-adjusted lifespan and more than 0.5 percent of the global burden of illness. The market is projected to expand as the number of instances of Alzheimer’s disease among the elderly population rises. However, the market is expected to be hampered by the adoption of strict government rules for the authorization of commercial use of biomarkers, as well as increasing ethical problems surrounding early detection of Alzheimer’s and Parkinson’s diseases. Whereas, the growth in demand for customized medicine is expected to provide opportunities for neurological biomarker market growth in forecasting years.

The main regions of Asia Pacific, North America, Europe, Latin America, and the Rest of the World are included in the geographical analysis of the worldwide Neurological Biomarkers market. North America held the largest market share in 2020 and is anticipated to expand at a significant CAGR throughout the forecast period. The region’s dominance is due to a considerable rise in illness burden, adoption of biomarkers for diagnostic, therapeutic development, and prognostic reasons, and increased research funding. Furthermore, in forecasting years, Asia Pacific is anticipated to expand at the fastest CAGR. The Asia Pacific region is projected to be driven by an increase in the number of clinical trials undertaken in emerging nations such as India and China, increased illness burden, and growing demand for targeted medicines in the central nervous system.

Major market player included in this report are:
Abbott Laboratories
Thermo Fisher Scientific, Inc.
Bio-Rad Laboratories, Inc.
Merck & Co., Inc.
Johnson & Johnson Services, Inc.
Banyan Biomarkers, Inc.
Myriad Genetics, Inc.
DiaGenic ASA
Quanterix
Myriad RBM
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Application:
Alzheimer’s Disease
Parkinson’s Disease
Multiple Sclerosis
Autism Spectrum Disorder
Others
By Type:
Genomic
Proteomic
Metabolomic
Imaging
Others
By End-use:
Hospital & Hospital Laboratories
Independent Clinical Diagnostic Centers
Research Organizations and Others
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2018, 2019
Base year – 2020
Forecast period – 2021 to 2027

Target Audience of the Global Neurological Biomarkers Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2027 (USD Billion)
1.2.1. Neurological Biomarkers Market, by Region, 2019-2027 (USD Billion)
1.2.2. Neurological Biomarkers Market, by Application, 2019-2027 (USD Billion)
1.2.3. Neurological Biomarkers Market, by Type, 2019-2027 (USD Billion)
1.2.4. Neurological Biomarkers Market, by End-use, 2019-2027 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Neurological Biomarkers Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Neurological Biomarkers Market Dynamics
3.1. Neurological Biomarkers Market Impact Analysis (2019-2027)
3.1.1. Market Drivers
3.1.1.1. Rising prevalence of neurological diseases
3.1.1.2. Increasing investment for R&D activities
3.1.2. Market Challenges
3.1.2.1. Lack of consumer awareness
3.1.3. Market Opportunities
3.1.3.1. Development in technology in biomarkers
Chapter 4. Global Neurological Biomarkers Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2018-2027)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
Chapter 5. Global Neurological Biomarkers Market, by Application
5.1. Market Snapshot
5.2. Global Neurological Biomarkers Market by Application, Performance – Potential Analysis
5.3. Global Neurological Biomarkers Market Estimates & Forecasts by Application 2018-2027 (USD Billion)
5.4. Neurological Biomarkers Market, Sub Segment Analysis
5.4.1. Alzheimer’s Disease
5.4.2. Parkinson’s Disease
5.4.3. Multiple Sclerosis
5.4.4. Autism Spectrum Disorder
5.4.5. Others
Chapter 6. Global Neurological Biomarkers Market, by Type,
6.1. Market Snapshot
6.2. Global Neurological Biomarkers Market by Type, Performance-Potential Analysis
6.3. Global Neurological Biomarkers Market Estimates & Forecasts by Type, 2018-2027 (USD Billion)
6.4. Neurological Biomarkers Market, Sub Segment Analysis
6.4.1. Genomic
6.4.2. Proteomic
6.4.3. Metabolomic
6.4.4. Imaging
6.4.5. Others
Chapter 7. Global Neurological Biomarkers Market, by End-use,
7.1. Market Snapshot
7.2. Global Neurological Biomarkers Market by End-use, Performance-Potential Analysis
7.3. Global Neurological Biomarkers Market Estimates & Forecasts by End-use, 2018-2027 (USD Billion)
7.4. Neurological Biomarkers Market, Sub Segment Analysis
7.4.1. Hospital & Hospital Laboratories
7.4.2. Independent Clinical Diagnostic Centers
7.4.3. Research Organizations and Others
Chapter 8. Global Neurological Biomarkers Market, Regional Analysis
8.1. Neurological Biomarkers Market, Regional Market Snapshot
8.2. North America Neurological Biomarkers Market
8.2.1. U.S. Neurological Biomarkers Market
8.2.1.1. Application breakdown estimates & forecasts, 2018-2027
8.2.1.2. Type breakdown estimates & forecasts, 2018-2027
8.2.1.3. End-use breakdown estimated & forecasts, 2018-2027
8.2.2. Canada Neurological Biomarkers Market
8.3. Europe Neurological Biomarkers Market Snapshot
8.3.1. U.K. Neurological Biomarkers Market
8.3.2. Germany Neurological Biomarkers Market
8.3.3. France Neurological Biomarkers Market
8.3.4. Spain Neurological Biomarkers Market
8.3.5. Italy Neurological Biomarkers Market
8.3.6. Rest of Europe Neurological Biomarkers Market
8.4. Asia-Pacific Neurological Biomarkers Market Snapshot
8.4.1. China Neurological Biomarkers Market
8.4.2. India Neurological Biomarkers Market
8.4.3. Japan Neurological Biomarkers Market
8.4.4. Australia Neurological Biomarkers Market
8.4.5. South Korea Neurological Biomarkers Market
8.4.6. Rest of Asia Pacific Neurological Biomarkers Market
8.5. Latin America Neurological Biomarkers Market Snapshot
8.5.1. Brazil Neurological Biomarkers Market
8.5.2. Mexico Neurological Biomarkers Market
8.6. Rest of The World Neurological Biomarkers Market

Chapter 9. Competitive Intelligence
9.1. Top Market Strategies
9.2. Company Profiles
9.2.1. Abbott Laboratories
9.2.1.1. Key Information
9.2.1.2. Overview
9.2.1.3. Financial (Subject to Data Availability)
9.2.1.4. Application Summary
9.2.1.5. Recent Developments
9.2.2. Thermo Fisher Scientific, Inc.
9.2.3. Bio-Rad Laboratories, Inc.
9.2.4. Merck & Co., Inc.
9.2.5. Johnson & Johnson Services, Inc.
9.2.6. Banyan Biomarkers, Inc.
9.2.7. Myriad Genetics, Inc.
9.2.8. DiaGenic ASA
9.2.9. Quanterix
9.2.10. Myriad RBM
Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption

At Bizwit Research and Consultancy, we employ a thorough and iterative research methodology with the goal of minimizing discrepancies, ensuring the provision of highly accurate estimates and predictions over the forecast period. Our approach involves a combination of bottom-up and top-down strategies to effectively segment and estimate quantitative aspects of the market, utilizing our proprietary data & AI tools. Our Proprietary Tools allow us for the creation of customized models specific to the research objectives. This enables us to develop tailored statistical models and forecasting algorithms to estimate market trends, future growth, or consumer behavior. The customization enhances the accuracy and relevance of the research findings.
We are dedicated to clearly communicating the purpose and objectives of each research project in the final deliverables. Our process begins by identifying the specific problem or challenge our client wishes to address, and from there, we establish precise research questions that need to be answered. To gain a comprehensive understanding of the subject matter and identify the most relevant trends and best practices, we conduct an extensive review of existing literature, industry reports, case studies, and pertinent academic research.
Critical elements of methodology employed for all our studies include:
Data Collection:
To determine the appropriate methods of data collection based on the research objectives, we consider both primary and secondary sources. Primary data collection involves gathering information directly from various industry experts in core and related fields, original equipment manufacturers (OEMs), vendors, suppliers, technology developers, alliances, and organizations. These sources encompass all segments of the value chain within the specific industry. Through in-depth interviews, we engage with key industry participants, subject-matter experts, C-level executives of major market players, industry consultants, and other relevant experts. This allows us to obtain and validate critical qualitative and quantitative information while evaluating market prospects. AI and Big Data are instrumental in our primary research, providing us with powerful tools to collect, analyze, and derive insights from data efficiently. These technologies contribute to the advancement of research methodologies, enabling us to make data-driven decisions and uncover valuable findings.
In addition to primary sources, we extensively utilize secondary sources to enhance our research. These include directories, databases, journals focusing on related industries, company newsletters, and information portals such as Bloomberg, D&B Hoovers, and Factiva. These secondary sources enable us to identify and gather valuable information for our comprehensive, technical, market-oriented, and commercial study of the market. Additionally, we utilize AI algorithms to automate the collection of vast amounts of data from various sources such as surveys, social media platforms, online transactions, and web scraping. And employ Big Data technologies for storage and processing of large datasets, ensuring that no valuable information is missed during the data collection process.
Data Analysis:
Our team of experts carefully examine the gathered data using suitable statistical techniques and qualitative analysis methods. For quantitative analysis, we employ descriptive statistics, regression analysis, and other advanced statistical methods, depending on the characteristics of the data. This analysis may also incorporate the utilization of AI tools and big data analysis techniques to extract meaningful insights.
To ensure the accuracy and reliability of our findings, we extensively leverage data science techniques, which help us minimize discrepancies and uncertainties in our analysis. We employ Data Science to clean and preprocess the data, ensuring its quality and reliability. This involves handling missing data, removing outliers, standardizing variables, and transforming data into suitable formats for analysis. The application of data science techniques enhances our accuracy, efficiency, and depth of analysis, enabling us to stay competitive in dynamic market environments.
Market Size Estimation:
Our proprietary data tools play a crucial role in deriving our market estimates and forecasts. Each study involves the creation of a unique and customized model. The model incorporates the gathered information on market dynamics, technology landscape, application development, and pricing trends. AI techniques, such as machine learning and deep learning, aid us to analyze patterns within the data to identify correlations, trends, and relationships. By recognizing patterns in consumer behavior, purchasing habits, or market dynamics, our AI algorithms aid us in more precise estimations of market size. These factors are simultaneously analyzed within the model, allowing for a comprehensive assessment. To quantify their impact over the forecast period, correlation, regression, and time series analysis are employed.
To estimate and validate the market size, we employ both top-down and bottom-up approaches. The preference is given to a bottom-up approach, where key regional markets are analyzed as separate entities. This data is then integrated to obtain global estimates. This approach is crucial as it provides a deep understanding of the industry and helps minimize errors.
In our forecasting process, we consider various parameters such as economic tools, technological analysis, industry experience, and domain expertise. By taking all these factors into account, we strive to produce accurate and reliable market forecasts. When forecasting, we take into consideration several parameters, which include:
Market driving trends and favorable economic conditions
Restraints and challenges that are expected to be encountered during the forecast period.
Anticipated opportunities for growth and development
Technological advancements and projected developments in the market
Consumer spending trends and dynamics
Shifts in consumer preferences and behaviors.
The current state of raw materials and trends in supply versus pricing
Regulatory landscape and expected changes or developments.
The existing capacity in the market and any expected additions or expansions up to the end of the forecast period.
To assess the market impact of these parameters, we assign weights to each one and utilize weighted average analysis. This process allows us to quantify their influence on the market and derive an expected growth rate for the forecasted period. By considering these various factors and applying a weighted analysis approach, we strive to provide accurate and reliable market forecasts.
Insight Generation & Report Presentation:
After conducting the research, our experts analyze the findings in relation to the research objectives and the specific needs of the client. They generate valuable insights and recommendations that directly address the client’s business challenges. These insights are carefully connected to the research findings to provide a comprehensive understanding.
Next, we create a well-structured research report that effectively communicates the research findings, insights, and recommendations to the client. To enhance clarity and comprehension, we utilize visual aids such as charts, graphs, and tables. These visual elements are employed to present the data in an engaging and easily understandable format, ensuring that the information is accessible and visually appealing to the client. Our aim is to deliver a clear and concise report that conveys the research findings effectively and provides actionable recommendations to meet the client’s specific needs.

Need Assistance

Contact Person -
Krishant Mennon
Call us @
+ 91 99931 15879
Email: sales@bizwitresearch.com

Checkout

Why Choose Us?

Quality over Quantity

Backed by 60+ paid data sources our reports deliver crisp insights with no compromise quality.

Analyst Support

24x7 Chat Support plus
free analyst hours with every purchase

Flawless Methodology

Our 360-degree approach of market study, our research methods leave stones unturned.

Enquiry Now